Podcasts about Integration

Even if you're Christian — even if your spouse is a genuinely good person — you can still feel deeply unfulfilled. In this episode, Dr. Greg explores how asking another person to carry your identity, security, and worth turns love into survival — and leaves both people depleted. Key Topics: How misplaced dependence slowly erodes love Why identity collapses when relationships become sources of self-worth The difference between free self-gift and anxious attachment How to properly order your love Learn More: Pilgrimage to Poland - Learn more about this interior journey with St. John Paul II Summit of Integration 2026 - Sign up to learn more about this year's event! Healing Retreat in Wyoming - Learn more about our upcoming retreat experience. Being Human episodes on the Dependent Defense Pattern: Ep. #267: Not All Satisfaction Is Good: Understanding Codependency As Relationship Cancer Ep. #266: You're Giving Too Much! Uncovering How Anxiety Disguises Itself as Holiness Ep. #265: Jerry Maguire, Gollum, and the Fear of Not Existing Gaudium et Spes - Pastoral Constitution on the Church in the Modern World by Pope Paul VI Need help? Schedule a free CatholicPsych consultation Want to help? Learn more about our Certification in Professional Accompaniment Follow Us on Socials:   Instagram | Facebook | YouTube | Twitter (X) | LinkedIn

Running the PESO Model®as separate tactics creates noise, not momentum. In this episode, Gini Dietrich shares what PESO Model integration really is: repeatable decisions, a stop list that prevents chaos, and a one-page integration map that keeps everything connected.

Health Affairs' Rob Lott interviews Derek T. Lake on his recent paper exploring new research on Optum's acquisitions, finding the company tended to buy physician practices already using ambulatory surgery centers and that its ASC acquisitions were followed by higher prices for competing insurers.Order the February 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

Your psyche becomes fragmented because of suppressed emotions and unintegrated past experiences. These suppressed energies block the natural upward flow of Shakti, which leads to psychological suffering and confusion. Trying to fix internal issues by changing the outside world only results in temporary relief and greater entanglement. True spiritual growth comes from releasing the suppressed parts of yourself, practicing non-resistance, and refusing to store more disturbances. By doing this, you become whole, integrated, and attuned to the divine energy within, realizing you were always a great being all along. © Sounds True Inc. Episodes: © 2026 Michael A. Singer. All Rights Reserved.

Welcome to the March Q&A episode!Topics discussed include:- Do Nested Goals work in the work setting, and if so, would you do the planning for both at the same time, or separate things out?(Episode mentioned: https://theshubox.com/2026/01/ep-285-sextiles-morning-pages-goals-lists-and-more-listener-tips-qa.html)- How to plan your planning (very meta - but seriously!) - both at larger and smaller time scales- How to plan for community engagement or activism?- Seeking help on syncing Outlook and Google Calendar (listener wisdom requested!)- Suggestions for mood trackingPlus, listener Stephanie gives her take on Ramona & Ruth Planners: (https://www.ramonaandruth.com) Episode Sponsors IXL:  Make an impact on your child's learning, get IXL now. Best Laid Plans  listeners can get an exclusive 20% off IXL membership when they sign up today at https://www.ixl.com/plans.  Green Chef:  Healthy meals that fit your nutrition goals (and are delicious too!).  Head to Greenchef dot com/50bestlaid and use code 50bestlaid to get fifty percent off your first month, then twenty percent off for two months with free shipping.  Mint Mobile:  Save money by changing your wireless plan to Mint Mobile!  Shop plans at mintmobile.com/BLP.  PrepDish: Healthy meal plans straight to your inbox (and now with easy Instacart ordering!).  Visit ⁠⁠⁠⁠prepdish.com/plans⁠⁠⁠⁠ for a free 2-week trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

Eric Byunn of Centana Growth joins Nick to discuss The Future of Fintech, If VC Growth Has Become a New Asset Class, and the Case For and Against Vertical Integration in the AI Age. In this episode we cover: Due Diligence and Value Creation Investment in Jumio and Identity Verification Growth Expectations and Market Realities Lessons from Netscape and Industry Evolution Investor Responsiveness and Connectivity Guest Links: Eric's LinkedIn Centana Growth Partners' LinkedIn Centana Growth Partners' Website The host of The Full Ratchet is Nick Moran of New Stack Ventures, a venture capital firm committed to investing in founders outside of the Bay Area. We're proud to partner with Ramp, the modern finance automation platform. Book a demo and get $150—no strings attached.   Want to keep up to date with The Full Ratchet? Follow us on social. You can learn more about New Stack Ventures by visiting our LinkedIn and Twitter.

Episode: 1533 The Triple Nickel: the first Black paratroopers become smoke jumpers.  Today, a secret WW-II battle.

In Part 2 of our conversation with Leo Gura, the discussion moves from abstract truth into the territory most people avoid: morality, evil, love, and survival. If everything is one, what becomes of good and bad? If reality is infinite consciousness, are our moral systems discoveries or inventions shaped by fear and self-preservation? The episode wrestles with whether absolute truth dissolves morality or reveals a deeper foundation beneath it, and what it would mean to live from that realization without collapsing into nihilism.Part 1: https://youtu.be/rLYFHXf1xXUPATREON https://www.patreon.com/c/demystifysciPARADOX LOST PRE-SALE: https://buy.stripe.com/7sY7sKdoN5d29eUdYddEs0bHOMEBREW MUSIC - Check out our new album!Hard Copies (Vinyl): FREE SHIPPING https://demystifysci-shop.fourthwall.com/products/vinyl-lp-secretary-of-nature-everything-is-so-good-hereStreaming:https://secretaryofnature.bandcamp.com/album/everything-is-so-good-herePARADIGM DRIFThttps://demystifysci.com/paradigm-drift-show00:00 Go!00:03:55 Good, Bad, and Absolute Ontology00:06:17 Stages of Moral Development00:09:41 Expanding the Self to Infinity00:12:03 Relative vs Absolute Morality00:17:24 Accountability Within Oneness00:21:35 Law, Consent, and Moral Relativism00:27:22 When Love Becomes Naive00:30:24 Survival Corrupts Pure Ideas00:33:02 Radical Open-Mindedness00:37:13 Good and Evil as Human Constructs00:42:01 Can Evil Exist Ontologically?00:46:16 Trauma, Awakening, and Survival00:51:10 Jesus, Suffering, and Infinite Love00:55:06 Ontology of Love and Infinity00:59:05 Infinity, God, and Absolute Reality01:06:40 Unity in Nature and Daily Life01:11:18 Integration and Practical Awakening01:16:23 Consciousness Beyond Humanity01:19:41 Immortality Through Infinity01:21:20 Closing Reflections and Invitation #Nonduality, #Consciousness, #Awakening, #AbsoluteTruth, #PhilosophyOfMind, #MoralPhilosophy, #InfiniteLove, #SelfInquiry, #SpiritualAwakening, #TruthSeeking, #PhilosophicalDebate, #skepticism , #physicspodcast, #philosophypodcast MERCH: Rock some DemystifySci gear : https://demystifysci-shop.fourthwall.com/AMAZON: Do your shopping through this link: https://amzn.to/3YyoT98DONATE: https://bit.ly/3wkPqaDSUBSTACK: https://substack.com/@UCqV4_7i9h1_V7hY48eZZSLw@demystifysci RSS: https://anchor.fm/s/2be66934/podcast/rssMAILING LIST: https://bit.ly/3v3kz2S SOCIAL: - Discord: https://discord.gg/MJzKT8CQub- Facebook: https://www.facebook.com/groups/DemystifySci- Instagram: https://www.instagram.com/DemystifySci/- Twitter: https://twitter.com/DemystifySciMUSIC: -Shilo Delay: https://g.co/kgs/oty671

On this episode, Brian completes our review of the Octet Chapter, or the Book of Eights, with a recap and integration session. Next week will be our (almost) Spring Hybrid Retreat, details can be found here. Starting on March 7th, we'll begin a series on Ajahn Sumedho's book on the Four Noble Truths, information for that can be found on the Classes page of the website.   Should you have any questions, or wish to join us via Zoom, please Contact us via our website.    If you are subscribed to our Podcast on Podbean, iTunes, or Spotify you will receive notifications when new episodes are posted.  

Arthur Herman argues that the American worldview rests on three Scottish pillars: unity of knowledge, common sense, and the harmonious integration of modern scientific discovery with ancient religious revelation. 4.1900 MEXICO

Send a textIn this episode of the Endless Possibilities podcast, Gareth Duignam explores the concept of spiritual bypassing, where individuals use spirituality to avoid facing unresolved emotional wounds. He discusses the importance of shadow work, the dangers of spiritual consumerism, and how relationships serve as mirrors for our inner struggles. The conversation emphasizes the need for humility, self-awareness, and the courage to confront our shadows in order to achieve true spiritual growth and integration.Spiritual bypassing is using spirituality to avoid emotional wounds.Shadow work is essential for true integration of spiritual experiences.Relationships reveal our shadows and unresolved issues.Humility and beginner's mind are crucial in spiritual growth.Spiritual consumerism can lead to a cycle of avoidance.Feeling emotions is necessary for healing and freedom.The light we seek is within, not in external experiences.Awakening involves embracing our full humanity, including our shadows.Storytelling can create separation from reality and ourselves.Integration requires grounding spiritual experiences in our human reality.

This podcast, recorded live during CEDIA Expo/CIX 2025, dives into the world of Leon Speakers. Caitlin Stewart, director of sales, shares how the company blends innovative design with cutting-edge audio solutions. Watch this podcast to learn about Leon's Ann Arbor roots, their collaborations with architects and designers, and everything in between. This episode of Inside Buzz also explores the importance of design thinking, illuminates industry trends and discusses the power of creative partnerships.

The PMP exam is evolving again.Starting July 2026, PMI is rolling out updates that reflect where project management is actually headed — hybrid delivery models, AI integration, data-driven decision-making, and stronger business alignment.If you're thinking about getting certified, already studying, or training others, this is not the time to drift.This is the time to get it sorted.What's Likely Changing?While PMI doesn't overhaul everything overnight, updates typically reflect:Greater emphasis on hybrid and adaptive deliveryMore real-world business acumen and strategic thinkingStronger focus on leadership influence over technical memorizationDeeper integration of technology, automation, and AI-enabled workflowsScenario-heavy questions that test judgment under pressureTranslation: less textbook recall, more applied thinking.What This Means for YouIf you plan to take the PMP before July 2026:You still have a window to prepare under the current structure.Your study materials remain valid.Momentum matters — don't stall.If you're taking it after July 2026:Expect refined domains.Expect updated examples.Expect more real-world nuance.Expect decision-making depth over process trivia.The fundamentals won't disappear — Integration, Scope, Schedule, Cost, Risk, Stakeholders — those pillars stay.But how they are tested will continue shifting toward leadership and business impact.The Bigger PictureThe PMP is not becoming easier.It's becoming more relevant.PMI is aligning the credential with how projects are actually delivered in 2026:Distributed teamsCloud infrastructureAI-supported planningContinuous delivery environmentsBusiness-first accountabilityThat means you can't just memorize outputs.You must understand flow.You must understand intent.You must understand why.What You Should Do NowDecide your timeline.Commit to a structured study plan.Focus on logic and sequencing — not rote memorization.Practice scenario-based questions.Build judgment, not just recall.If you've been “thinking about” PMP… stop thinking.Act.July 2026 is not far away.Get it sorted.

What if the strategies you've used to avoid pain are the same ones keeping you disconnected from your soul? So much of our desire to strive and optimize is simply the ego's way of protecting us from discomfort. We call it growth, but in reality, it's avoidance. My guest today is my good friend Kyle Cease. Kyle was named one of Comedy Central's Top 10 Comics to Watch in 2009, and he's the author of my favorite book I read in 2025, The Illusion of Money. He was on the path to Hollywood stardom until something deeper called him to do what he was destined to do: become a spiritual teacher. Not to achieve more fame or money, but to develop a deeper connection to God, truth, and spiritual growth.  In this episode, we go deeper than I've ever gone on this podcast. We talk about how the internet is bombarding us with first-level insights, why "positive thinking" fails to overcome our personal struggles, and how our addiction to impact, productivity, and even self-help can keep us from real healing. Kyle also shares how he's learning to let his ego die, how suffering is necessary in order to truly heal, and why connecting with your soul on a deeper level will unlock your biggest breakthroughs to achieve your goals. KEY TAKEAWAYS Inheriting Fear and Shame From Our Parents Your Soul Wants the Full Human Experience The Subtle Ways We Avoid Suffering Insight vs. Integration in Self-Development Why Breakthroughs Require Earned Revelation Ego vs. Soul: Redefining Productivity Perspectives on Unconditional Love and Free Will Honoring God to Kill Your Ego What It Means to Merge With Your Soul Freedom From Needing to Leave a Legacy How to Connect & Get Access to Kyle's Courses Get The Full Show Notes To get full access to today's show notes, including audio, transcript, and links to all the resources mentioned, visit MiracleMorning.com/626 Subscribe, Rate & Review I would love if you could subscribe to the podcast and leave an honest rating & review. This will encourage other people to listen and allow us to grow as a community. The bigger we get as a community, the bigger the impact we can have on the world. To subscribe, rate, and review the podcast on iTunes, visit HalElrod.com/iTunes. Connect with Hal Elrod Facebook Twitter Instagram YouTube   Copyright © 2026 Miracle Morning, LP and International Literary Properties LLC

Hello Seekers! Ben here, today Jacques, Hesse and I are joined by our dear Mr. Max to discuss the Gay Tech Mafia allegedly operating in Silicon Valley. Then Max's co-host on the Drain, Dave Kempa, joins us for a preview of their show about California politics. Intro & Outro–Yerba Brava, Como Te Voy A Olvidar

Voice agents are moving from novelty to true revenue infrastructure—and businesses that treat them like strategic roles instead of talking FAQs are pulling ahead. In this episode, John Jantsch sits down with Ryan Murha of Yodify to explore how purpose-built voice AI agents can qualify leads, guide buyers, facilitate conversations, and even create new revenue streams for creators and brands. They break down how multi-layered LLM orchestration, brand voice alignment, and AI guardrails reduce hallucinations and improve real-world performance. If you're curious about using voice AI for business development, customer experience automation, or scalable personalization, this conversation shows why voice AI is finally ready for prime time. Today we discussed: 00:00 Voice AI Fundamentals 02:32 Prompt Strategy, Personas, and Sales Roles 05:17 Critically Thinking Voice Agents 08:33 Voice Agent Framework 10:02 AI Transparency, Ethics, and Trust 11:43 Building and Testing AI Agents 14:59 Guardrails, Gemini, and Limitations 16:41 Integration, Monetization, and Pilots 19:59 Closing Thoughts and Contact Info Rate, Review, & Follow If you liked this episode, please rate and review the show. Let us know what you loved most about the episode. Struggling with strategy? Unlock your free AI-powered prompts now and start building a winning strategy today!

Canine integration into SWAT operations has evolved significantly, with the Los Angeles County Sheriff's Department Special Enforcement Bureau leading the charge since the 1990s. In this episode, Jon sits down with John Montenegro and Steve Williams from LASD-SEB to examine their pioneering approach to K9/SWAT integration, where canines and operators function as a single team with complementary capabilities. Montenegro and Williams share tactical insights from decades of experience, debrief actual cases demonstrating effective canine deployment, and discuss lessons learned in building successful integration programs. Essential listening for tactical teams considering or refining their K9 integration strategies.

Integration is usually told as a win—full stop. This episode explores the side rarelydiscussed: what Black communities lost in the process.See omnystudio.com/listener for privacy information.

Wellness isn't just physical—and it's rarely complicated. In this themed episode of Vibe Science, Ryan Alford explores the mind–body connection, emotional resilience, and why many modern wellness approaches fail by overcomplicating what's inherently natural. Drawing from personal experience, ancient healing traditions, and modern science, the discussion covers: How emotional triggers create ongoing stress and suffering Why you can't always change circumstances—but you can change your response Trauma release, forgiveness, and subconscious patterning The placebo effect and belief-driven healing Plant medicine, rituals, and nature-based wellness Why application matters more than endless information Balancing modern technology with ancient wisdom This conversation is a reminder that true health comes from awareness, simplicity, and integration—not chasing the next trend. Connect with the Host Ryan Alford Instagram: https://www.instagram.com/ryanalford Website:

 Modernizing your payment system definitely improves customer experience, but could it also be improving your bottom line?? Steve Marcionetti, President and Founder of CCI (Card Concepts Inc), shares insights on payment system options, the strategies behind implementation, and the ROI you can expect. Referenced Links: Our Sponsors: H-M Company Drain Troughs: https://www.draintroughs.com , Alliance Laundry Systems: https://go.speedqueencommercial.com/LM-SQ-Podcast113-February26 & LaundroBoost: https://laundroboostmarketing.comOur Guest: Steve Marcionetti's socials: http://www.linkedin.com/in/stevemarcionetti , https://www.facebook.com/marcionetti , https://www.instagram.com/ccisteve/ , https://www.tiktok.com/@ccisteve , https://www.youtube.com/@cardconceptsinc8471Card Concepts Inc: https://www.laundrycard.com/Laundry Concepts Distribution: https://www.laundryconcepts.com/Our Website: https://www.laundromatmillionaire.comOur Online Course: https://dave-menz.mykajabi.com/sales-pageOur Youtube channel: https://youtube.com/c/LaundromatMillionaireOur Podcast: https://laundromatmillionaire.com/podcast/Our Facebook: https://www.facebook.com/laundromatmillionaire/Our Facebook Group: https://www.facebook.com/groups/laundromatmillionaireOur LinkedIn: https://www.linkedin.com/in/dave-laundromat-millionaire-menz/Our Instagram: https://www.instagram.com/laundromatmillionaire/Our laundromats: https://www.queencitylaundry.comOur pick-up and delivery laundry services: https://www.queencitylaundry.com/deliveryOur WDF & Delivery Workshop: https://laundromatmillionaire.com/pick-up-delivery-workshop/Suggested Services Page: https://www.laundromatmillionaire.com/servicesWDF & Delivery Dynamics: A Complete Business Blueprint: https://laundromatmillionaire.com/wdf-delivery-dynamics-a-business-blueprint/The Laundromat Millionaire Insurance Program: https://laundromatmillionaire.com/insurance/Timestamps 00:00 Episode 115 Intro – Steve Marcionetti01:24 Spotlight: Next Laundromat Millionaire Workshop02:45 Introduction to Steve Marcionetti and His Background07:07 Early Laundromat Card Systems08:42 The Launch of CCI and Its Impact on the Industry11:50 “Card Systems” – Loyalty vs Credit/Debit14:13 The Laundry Card System – Loyalty Cards16:05 The Financial Benefits of Loyalty Cards – The Float21:59 Innovative Marketing Strategies with Loyalty Cards29:37 CCI's Other Options: Laundry Card vs FASCard vs Flex RF35:53 Payment though Mobile App38:10 Ongoing Fees39:00 Laundry Card for Multi-Store Owners40:07 Data Ownership and On-Premise Solutions42:52 Industry Shift Back to Loyalty Cards44:58 Ownership of the Float and the Loyalty46:16 Product Lifespan and Updates53:04 Transitioning to Cashless: Strategies for Success58:15 Family Dynamics in Business1:02:09 Future of the Laundry Industry – Acquisitions & Consolidations?01:06:18 Innovations Coming in CCI's Payment Systems01:07:56 Compatibility & Integrations with Other Software01:11:24 Contact Info & Final Thoughts 

Bundesinnenminister Alexander Dobrindt von der CSU hat den Zugang zu Integrationskursen eingeschränkt. Nur noch Menschen mit bereits gesicherter Bleibeperspektive dürfen die Kurse auf staatliche Kosten besuchen. Dobrindts Entscheidung betrifft vor allem Asylbewerber im laufenden Verfahren, Geduldete und Geflüchtete aus der Ukraine. Die Begründung des Innenministers: Es muss gespart werden. Die SPD fühlt sich übergangen. WDR-Investigativjournalist Manuel Bewarder hat für die Recherchekooperation aus NDR, WDR und Süddeutscher Zeitung Einblick in die Gespräche hinter den Kulissen gesammelt, wo SPD und Union seit Tagen nach einer Lösung suchen. Er erzählt in dieser 11KM-Folge, warum Alexander Dobrindts Entscheidung die SPD kalt erwischt hat und welche Auswirkungen sie auf den Koalitionsfrieden haben kann. Alle aktuellen Nachrichten zum Thema Integrationskurse und Integration findet ihr auf der Themenseite der tagesschau: https://www.tagesschau.de/thema/integration In unserer Folge “Richter, Rente, Reformen: Wieviel Streit verträgt die Merz-Koalition?” schauen wir auf die ersten Monate der Regierung und fragen uns: Wieviel Streit kann die schwarz-rote Koalition noch vertragen? https://1.ard.de/11KM_Merz_Koalition 11KM ist beim ARD Sounds Festival dabei. Tickets bekommt ihr hier: https://www.ardsoundsfestival.de/#/Hier geht's zu “Politikum - Der Meinungspodcast”, unserem Podcast-Tipp: https://1.ard.de/politikum-der-meinungspodcast Diese und viele weitere Folgen von 11KM findet ihr überall da, wo es Podcasts gibt, auch hier in der ARD Audiothek: https://www.ardaudiothek.de/sendung/11km-der-tagesschau-podcast/12200383/ An dieser Folge waren beteiligt: Folgenautor: Marc Hoffmann Mitarbeit: Niklas Münch, Lukas Waschbüsch Host: Elena Kuch Produktion: Laura Picerno, Lorenz Kersten und Hanna Brünjes Planung: Nicole Dienemann und Hardy Funk Distribution: Kerstin Ammermann Redaktionsleitung: Yasemin Yüksel und Fumiko Lipp 11KM: der tagesschau-Podcast wird produziert von BR24 und NDR Info. Die redaktionelle Verantwortung für diese Episode liegt beim BR.

Depuis quand ça existe les TDAH ? Adhérez à cette chaîne pour obtenir des avantages : https://www.youtube.com/channel/UCN4TCCaX-gqBNkrUqXdgGRA/join ERRATUM à 6:21 lésion cérébrale mineure avec un e bien sûr! OUPS 00:00:00 - Introduction à l'histoire du diagnostic de TDAH 00:01:59 - Les premières tentatives 00:08:10 - Le début de la psychopharmacologie pour le TDAH 00:11:54 - L'impact de l'article du Washington Post 00:15:24 - La définition du TDAH par Russell Barkley 00:17:00 - Le diagnostic du TDAH au Québec   Pour soutenir la chaîne, au choix: 1. Cliquez sur le bouton « Adhérer » sous la vidéo. 2. Patreon: https://www.patreon.com/hndl Musique issue du site : epidemicsound.com Images provenant de https://www.storyblocks.com Abonnez-vous à la chaine: https://www.youtube.com/c/LHistoirenousledira Les vidéos sont utilisées à des fins éducatives selon l'article 107 du Copyright Act de 1976 sur le Fair-Use. Sources et pour aller plus loin: Marie-Christine Brault, Emma Degroote et Mieke Van Houtte, « Disparities in the prevalence of ADHD diagnoses, suspicion, and medication use between Flanders and Québec from the lens of the medicalization process », Health, 2023, vol. 27 (6), p. 958-979. Lange, K. W., Reichl, S., Lange, K. M., Tucha, L., & Tucha, O. (2010). The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord . 2010 Dec;2(4):241-55. doi: 10.1007/s12402-010-0045-8. Epub 2010 Nov 30. Rothenberger A, Neumärker KJ. Wissenschaftsgeschichte der ADHS. Steinkopff, Darmstadt: Kramer-Pollnow im Spiegel der Zeit; 2005. https://neuronup.com/fr/actualites-de-la-stimulation-cognitive/troubles-neuro-developpementaux/tdah/bref-historique-du-tdah-et-de-son-impact-sur-le-fonctionnement-executif/ Barkley 2006a, Barkley RA (2006a) Attention-deficit hyperactivity disorder. A Hand- book for Diagnosis and Treatment, Guilford, New York, Barkley, R. (2002). Niños hiperactivos: cómo comprender y atender sus necesidades especiales. 3a. Ed. Barcelona: Paidós. Barkley, R. (2011). Executive functioning and self- regulation: Integration, extended phenotype, and clinical implications. The Guilford Press. « Early History of ADHD », Russell Barkley, PhD - Dedicated to ADHD Science+, 19 septembre 2023. https://youtu.be/jwrhLpSlMPY?si=-9vm5G3ho2wMg-M8 « Neurodiversity Video #16 A History of ADHD », Thomas Armstrong, 4 juillet 2025. https://youtu.be/KIFFeEFLti4?si=3fpd-bb7KqvBK0ZZ https://www.verywellmind.com/adhd-history-of-adhd-2633127#citation-12 https://www.neurodiverging.com/the-history-of-attention-deficit-disorder/ The Story of Fidgety Philip.” The Evolution of A Disorder. Edward M. Hallowell, M.D. and John J. Ratey, M.D. https://theconversation.com/ritalin-at-75-what-does-the-future-hold-121591 https://daily.jstor.org/adhd-the-history-of-a-diagnosis/ https://www.washingtonpost.com/archive/lifestyle/wellness/1996/03/05/attention-deficit-disorder/c3c72c65-bd93-472d-aa99-3622ad6f5d36/ Robert R. Erk, « The evolution of attention deficit disorders terminology », Elementary School Guidance & Counseling, Vol. 29, No. 4 (April 1995), pp. 243-248. Lawrence H. Diller, « The Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s », The Hastings Center Report, Vol. 26, No. 2 (Mar. - Apr., 1996), pp. 12-18 Autres références disponibles sur demande. #histoire #documentaire #tdah #tda #adhd

────────────────────────────────────────[00:02:09:27] — Operating System ID Mandate Centralizes ControlA Colorado Senate bill proposes embedding identity verification directly into operating systems, concentrating regulatory power into a few dominant tech companies while undermining open-source alternatives.────────────────────────────────────────[00:04:54:24] — Embedded Identity Tracking at the Core of Digital InfrastructureThe proposal would require operating system providers to collect birth data and track users from account creation, shifting enforcement from apps to foundational infrastructure for centralized monitoring.────────────────────────────────────────[00:05:15:04] — Structural Governance Shift Toward Federal ReplicationEmbedding identity enforcement at the operating-system layer is framed as a structural transformation likely to spread beyond the state level and reshape governance mechanisms.────────────────────────────────────────[00:09:26:05] — Mandatory Digital Identity as the Endpoint of Policy TrajectoryUniversal age verification is described as leading toward mandatory identity authentication for internet access, effectively eliminating anonymous online activity.────────────────────────────────────────[00:22:09:09] — Federal Emergency Powers and Industrial Compulsion MechanismsEmergency authorities enabling compelled production and liability protection are presented as aligning government power with private industry under centralized crisis-based governance.────────────────────────────────────────[00:42:02:27] — Expansion of Enforcement Power Beyond Constitutional ProcessDismissal of warrant requirements is framed as evidence of institutional drift away from constitutional safeguards toward more discretionary enforcement authority.────────────────────────────────────────[00:50:44:04] — Transnational Cartel Conflict and Security Spillover RiskEscalating cartel violence and militarized responses raise concerns about cross-border instability and expanding state-level security measures.────────────────────────────────────────[01:00:13:14] — Strategic Risk of War with Iran Amid Weakened AlliancesWarnings of depleted resources and reduced allied support highlight the geopolitical risks and potential overextension tied to confrontation with Iran.────────────────────────────────────────[01:11:53:23] — Multi-Front War Scenario and Regional Escalation RiskPreparations for strikes across multiple countries signal the potential expansion of conflict into a broader regional war framework.────────────────────────────────────────[01:19:24:11] — Nuclear Timeline Claims Driving War JustificationConflicting intelligence claims regarding Iran's nuclear capability are presented as a key justification for escalating military action.────────────────────────────────────────[01:23:14:13] — Tokenization and Digitalization as a New Control FrameworkExpansion of blockchain-based tokenization is framed as building an economic system capable of centralized monitoring and control over assets and transactions.────────────────────────────────────────[01:33:24:29] — Integration of Digital Identity with Biometric and Behavioral SystemsLinking identity, health, and behavioral data into programmable digital systems is described as forming a comprehensive surveillance and control architecture.──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

────────────────────────────────────────[00:02:09:27] — Operating System ID Mandate Centralizes ControlA Colorado Senate bill proposes embedding identity verification directly into operating systems, concentrating regulatory power into a few dominant tech companies while undermining open-source alternatives.────────────────────────────────────────[00:04:54:24] — Embedded Identity Tracking at the Core of Digital InfrastructureThe proposal would require operating system providers to collect birth data and track users from account creation, shifting enforcement from apps to foundational infrastructure for centralized monitoring.────────────────────────────────────────[00:05:15:04] — Structural Governance Shift Toward Federal ReplicationEmbedding identity enforcement at the operating-system layer is framed as a structural transformation likely to spread beyond the state level and reshape governance mechanisms.────────────────────────────────────────[00:09:26:05] — Mandatory Digital Identity as the Endpoint of Policy TrajectoryUniversal age verification is described as leading toward mandatory identity authentication for internet access, effectively eliminating anonymous online activity.────────────────────────────────────────[00:22:09:09] — Federal Emergency Powers and Industrial Compulsion MechanismsEmergency authorities enabling compelled production and liability protection are presented as aligning government power with private industry under centralized crisis-based governance.────────────────────────────────────────[00:42:02:27] — Expansion of Enforcement Power Beyond Constitutional ProcessDismissal of warrant requirements is framed as evidence of institutional drift away from constitutional safeguards toward more discretionary enforcement authority.────────────────────────────────────────[00:50:44:04] — Transnational Cartel Conflict and Security Spillover RiskEscalating cartel violence and militarized responses raise concerns about cross-border instability and expanding state-level security measures.────────────────────────────────────────[01:00:13:14] — Strategic Risk of War with Iran Amid Weakened AlliancesWarnings of depleted resources and reduced allied support highlight the geopolitical risks and potential overextension tied to confrontation with Iran.────────────────────────────────────────[01:11:53:23] — Multi-Front War Scenario and Regional Escalation RiskPreparations for strikes across multiple countries signal the potential expansion of conflict into a broader regional war framework.────────────────────────────────────────[01:19:24:11] — Nuclear Timeline Claims Driving War JustificationConflicting intelligence claims regarding Iran's nuclear capability are presented as a key justification for escalating military action.────────────────────────────────────────[01:23:14:13] — Tokenization and Digitalization as a New Control FrameworkExpansion of blockchain-based tokenization is framed as building an economic system capable of centralized monitoring and control over assets and transactions.────────────────────────────────────────[01:33:24:29] — Integration of Digital Identity with Biometric and Behavioral SystemsLinking identity, health, and behavioral data into programmable digital systems is described as forming a comprehensive surveillance and control architecture.──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Legendary LATAM Gringo Jakes' Website: https://jakenomada.com/ Twitter: https://x.com/JakeNomada $27 a month, unlimited data, 100+ countries = pangia pass Use my link for 10% off: https://pangiapass.com/a/bold Find Me Here: https://linktr.ee/bold.perceptions Travel / Lifestyle Consultation, DM Me On Instagram: bold_perceptions Subscribe to win a free flight.... when I hit 5k subscribers I will buy a random person a one way flight to experience solo travel themselves. & I will help you plan the adventure. Ai summary for seo ~ Latin America is a sprawling, high-contrast mosaic that defies any single label, offering a lifestyle that is as exhausting as it is exhilarating. To live here as a "gringo" is to enter a world where the social fabric is woven with deep-seated warmth and a collective resilience that prioritizes human connection over rigid schedules. Whether you are navigating the high-altitude Andean peaks or the humid pulse of a Caribbean coastline, you'll find a culture that operates on the "Tranquilo" principle—a fluid approach to time where bureaucracy is slow, but the coffee is fresh, the music is loud, and the people are genuinely curious about your story. It is a region that rewards the flexible and punishes the impatient. For those looking to plant roots, the "Gringo Trail" has evolved into a sophisticated network of hubs catering to different flavors of expatriate life. Mexico City and Medellín remain the heavyweights for digital nomads seeking cosmopolitan energy, world-class gastronomy, and robust infrastructure. Meanwhile, places like the Sacred Valley in Peru or the coastlines of Costa Rica offer a more soul-searching, "Pura Vida" existence focused on wellness and nature. In 2026, the influx of remote workers has pushed prices up in trendy neighborhoods like Roma Norte or El Poblado, but the cost of living still offers a "luxury-for-less" trade-off that is nearly impossible to find in the US or Europe, particularly regarding private healthcare and domestic services. However, the transition isn't always seamless, and "gringo" life requires a specific mental toolkit to navigate safely and respectfully. Safety is the most common concern, but it is often more about "situational awareness" than dodging cartels; it's about learning not to "give papaya"—local slang for not making yourself an easy target by flashing wealth. Beyond security, there is the hurdle of the "Gringo Tax," where foreigners are often quoted higher prices. Integration is the only cure for this; those who bother to learn the local Spanish (or Portuguese in Brazil) and respect the formal etiquette of the Usted find that the "foreigner" label eventually softens into that of a "local friend," unlocking a much deeper, more authentic version of the city. Ultimately, living in Latin America is an exercise in trading "First World" convenience for "Real World" vibrancy. You might lose a day to a confusing bank errand or a sudden power outage, but you'll gain a life filled with spontaneous Sunday asados, vibrant street markets, and a sense of community that makes the hyper-individualism of the North feel sterile by comparison. It is a place where the infrastructure might be crumbling in spots, but the spirit is unbreakable. If you can handle the noise, the spicy food, and the occasional chaos, it offers a richness of experience that makes it one of the most rewarding regions on earth to call home. #travel #travelblogger #nomad #latinamerica #expat #wifimoney

In this episode, I share actionable AI coaching strategies for guiding meaningful conversations with educators about integrating AI into their teaching practice. You'll also hear tips on identifying AI's role in workflows, addressing skepticism, and supporting hands-on collaboration to build confidence with AI tools. If you want to help your colleagues embrace AI effectively while keeping instructional goals at the center, this episode is for you! Show notes: https://classtechtips.com/2026/02/24/ai-coaching-359/ Sponsored by my Easy EdTech Club: https://EasyEdTechClub.com Follow Monica on Instagram: https://www.instagram.com/classtechtips/  Take your pick of free EdTech resources: https://classtechtips.com/free-stuff-favorites/   

The integration of Artificial Intelligence (AI) into post-injury rehabilitation is transforming recovery paradigms by enabling personalized, adaptive, and efficient rehabilitation pathways tailored to individual patient needs. This podcast reviews the current advances in AI applications that facilitate assessment, monitoring, and optimization of rehabilitation programs following injuries. Through machine learning algorithms, wearable sensors, and predictive analytics, AI enhances the precision of therapy plans, tracks patient progress in real-time, and predicts recovery trajectories. The discussion includes the benefits of AI-driven rehabilitation, including improved functional outcomes, reduced recovery times, and increased patient engagement. It also addresses challenges such as data privacy, algorithmic bias, and integration with clinical workflows.  1. Transforming recovery paradigms Traditional post‑injury rehab relies on periodic in‑person assessments, therapist intuition, and standardized protocols that only partially account for individual variability. AI is shifting this model toward: Continuous, data‑driven care: Instead of snapshots in clinic, rehab can be informed by near real‑time streams of kinematic, physiological, and behavioral data from wearables, smart devices, and robot interfaces. Dynamic adaptation: Therapy intensity, task difficulty, and exercise selection can be automatically adjusted based on ongoing performance, fatigue, and recovery trends, rather than fixed schedules. Precision rehabilitation: Algorithms can identify which patients are likely to respond to specific interventions (e.g., constraint‑induced movement therapy vs robotics) and tailor plans accordingly. This moves rehabilitation from a "one‑size‑fits‑many" paradigm toward precision, context‑aware therapy, analogous to precision oncology but focused on function and participation. 2. Assessment, monitoring, and optimization AI for assessment Sensor‑based movement analysis: Machine learning models process accelerometer, IMU, EMG, and pressure data to quantify gait symmetry, joint kinematics, balance, and fine motor control with higher resolution than visual observation alone. Automated scoring: AI can approximate or support standardized scales (e.g., Fugl‑Meyer, Berg Balance Scale) by mapping sensor features or video-derived pose estimates to clinical scores, reducing inter‑rater variability and saving clinician time. Continuous monitoring Home and community tracking: Wearable and ambient sensors enable monitoring of daily steps, walking speed, arm use, posture, and adherence to exercises outside the clinic, feeding rich longitudinal datasets into AI models. Real‑time alerts: Algorithms can detect abnormal patterns—such as increased fall risk, reduced limb use, or signs of over‑exertion—and flag the clinician or adjust digital therapy content automatically. Optimization and decision support Predictive models: Using historical data, AI can forecast functional gains, plateau points, or risk of complications (e.g., falls, readmission), supporting individualized goal‑setting and resource allocation. Reinforcement learning and "digital twins": Emerging work in neurorehabilitation treats rehab as a sequential decision problem, using model‑based reinforcement learning and patient "digital twins" to recommend optimal timing, dosing, and progression of interventions over weeks to months.​ 3. Technologies: ML, wearables, analytics Machine learning algorithms: Supervised ML classifies movement quality (normal vs compensatory), detects exercise type from sensor streams, and estimates clinical scores. Unsupervised learning clusters patients into phenotypes (e.g., gait patterns after stroke), revealing subgroups that respond differently to certain therapies. Reinforcement learning and contextual bandits explore which therapy adjustments yield the best long‑term functional outcomes for a given individual.​ Wearable sensors and robotics: Inertial sensors, EMG, pressure insoles, and exoskeleton sensors capture high‑frequency movement and muscle activity data during training. Robotic devices (upper‑limb exoskeletons, gait trainers) coupled with AI can modulate assistance, resistance, or task difficulty in real time based on performance and predicted fatigue. Predictive and prescriptive analytics: Predictive analytics estimate trajectories (e.g., time to independent walking, expected upper‑limb function) to inform shared decisions with patients and families. Prescriptive analytics recommend therapy intensity, modality mix, and scheduling to maximize functional gains under resource constraints. 4. Benefits: outcomes, efficiency, engagement Improved functional outcomes: Studies report better motor recovery, gait quality, and ADL performance when AI‑assisted training is used—especially when robotics and intelligent feedback are involved. Reduced recovery time and resource use: More precise dosing and earlier identification of non‑responders can reduce ineffective sessions, shorten time to key milestones, and support safe earlier discharge with robust remote follow‑up. Increased adherence and engagement: AI‑driven digital rehab platforms use gamification, adaptive difficulty, and personalized feedback to keep patients engaged in home programs, improving adherence compared to static paper instructions. Support for clinicians: Instead of replacing therapists, AI can offload repetitive measurement tasks, highlight concerning trends, and offer data‑driven suggestions, allowing clinicians to focus on relational, motivational, and complex decision‑making aspects of care. 5. Challenges and ethical considerations Data privacy and security: Rehab AI often relies on continuous collection of sensitive motion, physiological, and sometimes audio/video data, raising questions about consent, storage, secondary use, and breach risk. Approaches like federated learning and on‑device processing are being explored to reduce centralization of identifiable data while still enabling model training. Algorithmic bias and fairness: If training data under‑represent older adults, women, certain racial/ethnic groups, or people with severe disability, AI models may misestimate performance or risk for those groups, potentially widening disparities in rehab access and outcomes. Ongoing auditing, diverse datasets, and participatory design with patients and clinicians are needed to ensure equitable performance. Integration with clinical workflows: Many AI tools are developed in research settings and are not yet seamlessly integrated into EHRs, scheduling systems, or therapist documentation workflows. Poorly integrated tools risk adding documentation burden or "alert fatigue," reducing adoption. Successful implementations co‑design interfaces with frontline therapists and physicians. Regulation, liability, and trust: It remains unclear in many jurisdictions how to regulate adaptive rehab algorithms (as medical devices, clinical decision support, or wellness tools) and who is liable when AI‑informed plans cause harm.​ Transparent, explainable models and clear communication to patients about the role of AI are critical for maintaining trust. 6. Case studies and emerging trends Remote and hybrid digital rehabilitation: AI‑driven platforms providing home‑based stroke, orthopedic, or Parkinson's rehab with clinician dashboards are improving adherence and extending care beyond brick‑and‑mortar clinics. Collaborative AI for precision neurorehabilitation: Frameworks combining patient‑clinician goal setting, digital twins, and reinforcement learning exemplify "collaborative AI" that augments rather than replaces therapists.​ Multimodal personalization: Integration of movement data, EMG, heart rate, sleep, and self‑reported pain/fatigue is enabling more nuanced adaptation to daily fluctuations in capacity. Conversational AI for education and coaching: Early work is assessing tools like ChatGPT as low‑risk supports for exercise education and motivation, though they are not yet precise enough to replace professional plan design AI is moving rehab toward patient‑centered, continuously adapting, and data‑rich care, but realizing this promise depends on addressing privacy, bias, workflow, and regulatory challenges in partnership with clinicians and patients.

If your tongue could talk, it would tell you it affects far more than speech — from sleep quality and hormones to jaw development and restless kids. In this episode I interviewed Kristi Dobbs, a dental hygienist and myofunctional therapist from Roberts Integrative Dentistry, about how oral posture, nasal breathing, tongue-tie releases, and simple device and exercise-based therapies can transform sleep, behavior, pain, and overall health.What myofunctional therapy is: muscle-focused therapy for the face, tongue, jaw, and soft palate (like physical therapy for the neck up).Some modern lifestyle contributors to poor jaw development: softer diets, early solids/formula, early tooth removal and braces timing.Common signs linked to oral function problems: narrow palate, long face, gummy smile, mouth-breathing, snoring, TMJ, speech issues, picky eating, digestive problems, plantar fasciitis.The four pillars of myofunctional therapy: nasal breathing, lip seal, correct tongue posture, and proper swallowing.Device options: MyoMunchie (from ~6 months), Myobrace, Myo nozzle/Remplenish, and Invisalign palatal expansion when needed.Tongue-tie approach: pre- and post- myofunctional therapy plus a laser release and suturing to optimize outcomes and retrain function.Timing and commitment: therapy typically runs 12 sessions over ~6 months; results improve with ongoing maintenance exercises but require occasional practice to retain gains.Integration with other therapies: best results come when myofunctional therapy is combined with ENT, SLP, chiropractic, massage/lymphatic work, orthodontics, and other integrative providers.Virtual options: evaluations and much of the therapy can be done via telehealth; surgical procedures require an in-person provider.Contact Kristi Dobbs and Roberts Integrative Dentistry:Myofunctional Therapy Info: https://robertsintegrativedentistry.com/oral-myofunctional-therapy/Roberts Integrative Dentistry Phone and Email:  (417) 246-3029 and office@robertsintegrativedentistry.comMyofunctional Therapy can be performed virtually.Signs and symptoms of disordered breathing: https://mail.google.com/mail/u/1/#inbox/FMfcgzQfBkQwSbXXmnqckwjRmgSCfkTp?projector=1&messagePartId=0.1New Resource: Breast Health Guide - dailywellnesscommunity.com/breast-health-guide→ Please take 1 minute to show your support of the show!  Apple Podcasts: Sign in and scroll to the bottom to review!https://podcasts.apple.com/us/podcast/daily-wellness-podcast/id1651051841Spotify: Leave a rating and follow the show! (Click on the 3 dots.) https://podcasters.spotify.com/pod/show/melisha-meredithYouTube: Subscribehttps://www.youtube.com/@DailyWellnessCommunity-podcastConnect with Melisha and the Daily Wellness Communityinstagram.com/dailywellnesscommunity/facebook.com/dailywellnesscommunityWebsite: dailywellnesscommunity.comEmail us at: info@dailywellnesscommunity.comSome products I mention may be affiliate links, which means I may receive a small commission if you decide to make a purchase through one of my links. Our family greatly appreciates your support, it helps us keep creating the free resources we make for you all!DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider with any questions you may have. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

This week on the show, you're going to ride along with me from the incredibly comfortable and stylish VW ID.Buzz, which served as the mobile podcast studio at CEDIA Expo / CIX this September in Denver, Colorado. Were going back for more conversations from the show. Designer Resources Pacific Sales Kitchen and Home. Where excellence meets expertise. TimberTech – Real wood beauty without the upkeep CEDIA (Custom Electronic Design & Installation Association) is the global trade association for home technology professionals, specializing in smart home, automation, audio-visual, networking, and integrated systems. Its mission is to advance the home technology industry through education, certification, advocacy, and networking. Members include integrators, designers, manufacturers, and consultants who shape the connected environments we live and work in. CEDIA Expo is the industry's largest annual event for residential technology professionals. With hundreds of exhibitors, educational sessions, live demos, and global networking opportunities, it's where new ideas and innovations in smart home and AV integration take center stage. The Commercial Integrator Expo (CIX), co-located with CEDIA Expo, focuses on commercial integration technologies—from conferencing and IT infrastructure to building automation and emerging AV solutions—bringing together commercial integrators, IT pros, designers, and tech managers. Jason McGraw | Group VP and Show Director, CEDIA Expo / CIX Scope of the Show: McGraw details the scale of CEDIA Expo 2025, featuring over 350 exhibitors and immersive demo rooms that showcase integrated audio, video, and control systems. Integration Meets Design: Discussion centers on the critical partnership between integrators and the design-build community (interior designers, architects, builders). McGraw emphasizes that technology—ranging from AI and energy management to lighting—must be a foundational element of the design process, not an afterthought. The Business Case: Designers are encouraged to view integrators as essential trade partners, similar to electricians or plumbers, to better service clients and protect home networks. Dale Sandberg | Product Manager for Electronics, Sonance Aesthetic Performance: Sandberg discusses Sonance's philosophy that sound should support the design of a space rather than dominate it. The focus is on blending high-fidelity performance with discreet aesthetics. New Innovations: Highlights include the compact UA Series amplifiers designed to fit behind displays or in tight spaces, and the integration of professional-grade Blaze Audio amplifiers into the Sonance family. Outdoor Living: The conversation covers the growing trend of outdoor entertainment, where amplifiers and speakers are used to create immersive environments in backyards and outdoor kitchens. Jim Garrett | Senior Director of Product Strategy, Harman Luxury Audio Group Hidden Technology: Garrett addresses the challenge of eliminating “wall acne” through invisible speakers and design-integrated solutions that do not compromise acoustic performance. Pandemic Influence: The discussion explores how the pandemic shifted focus toward outdoor living and unconventional entertainment spaces, including garages and multi-generational gaming setups. Brand Portfolio: Insights into the product strategies for Harman's luxury brands—JBL, Revel, Mark Levinson, and JBL Synthesis—and the importance of gathering direct feedback from integrators to drive R&D. Links & Resources CEDIA Expo Commercial Integrator Expo NKBA – National Kitchen & Bath Association KBIS – Kitchen & Bath Industry Show Show Topics & Outline CEDIA Expo 2025 Snapshot Denver, Colorado Convention Center 350+ exhibiting brands, 100+ conference sessions, 115 manufacturer trainings Demo rooms showcasing integrated audio, video, and control systems The Wave Effect of Trade Shows Innovation as unseen currents shaping the industry Ideas incubated at CEDIA spreading across markets and returning as trends Integration Meets Design Town hall insights with CEDIA's Daryl Friedman & NKBA's Bill Darcy Bridging integrators with interior designers, kitchen & bath professionals, and architects Untapped opportunities in collaborative smart home projects Technology as a Design Driver AI, energy management, lighting trends, and seamless AV systems Why technology must be discussed at the start of design projects Case studies: motorized shades, outdoor AV, invisible speakers, custom veneers Outdoor Living & Luxury Spaces Kitchens and backyards as multi-hundred-thousand-dollar investments Expanding living spaces through technology Luxury demo rooms and high-performance home theaters Why Designers Should Be Here Missing out on competitive advantages without CEDIA exposure Seeing products in person vs. static web images Real examples of design-centric AV solutions and invisible tech The Business Case Designers need integrators just as they need electricians, plumbers, and fabricators Protecting networks and ensuring cybersecurity in the home Service and maintenance as part of the client experience Looking Forward Progress and serendipity at trade shows Extending collaboration with KBIS and IBS (Orlando, 2026) Building lasting bridges between integrators and designers Links & Resources CEDIA Expo Commercial Integrator Expo NKBA – National Kitchen & Bath Association KBIS – Kitchen & Bath Industry Show Dale Sandberg on Sonance, New Electronics, and Designing for Sonic + Aesthetic Experience Dale Sandberg, new Product Manager for Electronics at Sonance, shares how the company is blending high-fidelity performance with discreet design solutions, introducing amplifiers and loudspeakers that elevate both sonic and aesthetic experiences in residential and commercial spaces. At his first CEDIA Expo, Dale highlights Sonance's latest innovations, from compact UA Series amplifiers designed to disappear behind displays to Blaze Audio's professional-grade amplifiers now integrated into the Sonance family. With a philosophy that sound should enhance the design of a space rather than dominate it, Sonance is shaping how integrators and designers deliver immersive, comfortable experiences both indoors and out. Guest: Dale Sandberg, Product Manager for Electronics, Sonance. Background: from pro audio to Sonance, less than one year with the company. Context: first CEDIA Expo experience, excitement about Sonance's direction. New Product Highlights Loudspeakers High Output Series (professional side). Wedge speaker for outdoor/architectural blending. Re-engineered Power Pipe subwoofers for stronger low-end performance. UA Series Amplifiers Compact two-channel models (UA-125, ARC-enabled versions). Mountable behind TVs, under tables, or in tight spaces. Features T-slots for stacking/mounting other gear. Energy-efficient design with minimal heat output. Blaze Audio Amplifiers Sonance acquisition of Blaze Audio brand (Pascal, Denmark). Range from 60W per channel up to 400W bridged. Full DSP capability, rack-mountable, UL-rated. Outdoor applications via weather-rated cases. Design & Integration Perspective Compact electronics give designers freedom to hide gear while maintaining performance. Balancing performance and aesthetics: sound follows the design, not the other way around. Example: background music at parties that fills space without overwhelming conversation. Outdoor living trend: amplifiers and speakers enabling outdoor kitchens, theaters, and entertainment spaces. Company Ethos & Philosophy Mission: deliver complete audio solutions—amplification, processing, and speakers. Philosophy: the sonic experience should support the aesthetic experience of a home or space. Growth vision: expand residential dominance while building commercial presence. Takeaway: not just about volume—it's about creating the right experience. Jim Garrett | Harman Luxury Audio Jim Garrett on Harman's Audio Innovations, Hidden Tech, and Pandemic-Inspired Entertainment Jim Garrett, Senior Director of Product Strategy and Planning at Harman Luxury Audio Group, shares how the company balances high-performance audio with design aesthetics, explores emerging opportunities in outdoor and unconventional home entertainment, and highlights why integrator feedback is vital to shaping future products. From invisible speakers to immersive home cinema solutions, Jim Garrett takes listeners behind the scenes of Harman's engineering and R&D process, discussing product development for brands like JBL, Revel, Synthesis, and Mark Levinson. He explains how the pandemic inspired new entertainment spaces, how technology can be seamlessly integrated into interiors, and why CEDIA Expo remains an essential hub for innovation, collaboration, and awareness in the custom electronics industry. Guest: Jim Garrett, Senior Director of Product Strategy & Planning, Harman Luxury Audio Group. Role: Oversees product roadmap, development direction, and exhibition strategy. Context: Recorded in Volkswagen ID.Buzz at CEDIA Expo 2025. CEDIA Expo 2025 Overview Largest booth shared with parent company Samsung. Opportunity to engage integrators directly and gather actionable feedback. Importance of listening to installation professionals to improve products. Product Strategy and Brand Focus Harman Luxury Audio Group brands: JBL, JBL Synthesis, Revel, Mark Levinson. Focus at Expo: JBL Synthesis for home cinema and immersive audio. Solutions include invisible speakers, wall/ceiling installations, and custom home audio products. Balancing Performance and Aesthetics Challenge: high-performance products that are visually unobtrusive. Goal: eliminate “wall acne” with invisible or design-integrated speakers. Inspiration drawn from evolution in lighting design to minimize visual clutter. Engineering and R&D Harman's science-based approach: performance must meet visual and acoustic demands. Innovation includes weatherproof outdoor speakers and displays for bright sunlight. Teams challenged to create high-fidelity systems that integrate seamlessly into homes. Expanding Entertainment Spaces Pandemic influence: growth of outdoor living and unconventional entertainment areas. Multi-generational engagement: home theaters, garages, patios, bathrooms, and gaming setups. Flexibility of audio/video systems allows new experiences across the home. Integration and Awareness Educating interior designers, architects, and end users about hidden tech. Raising awareness of capabilities beyond audio: lighting, shades, HVAC, security integration. Emphasis on simplifying life at home while elevating performance and experience.

The Cognitive Crucible is a forum that presents different perspectives and emerging thought leadership related to the information environment. The opinions expressed by guests are their own, and do not necessarily reflect the views of or endorsement by the Information Professionals Association. During this episode, Doug Abdiel discusses the vivid operational problem of GPS-denied or GPS-degraded environments and how Advanced Navigation is helping operators cut through the fog of modern warfare. Recording Date: 16 Feb 2026 Research Question: Doug Abdiel suggests an interested student or researcher examine the computationally challenging problem of peer-to-peer solutions for signals. Resources: Cognitive Crucible Podcast Episodes Mentioned #237 Josh Segal on Ukraine, Electronic Warfare, and Fast Battlefield Innovation Advanced Navigation P&G Purpose: We believe that every person deserves a chance to obtain long-term, sustainable employment for themselves and their families. For some people, this has never been a problem. For others, through circumstances outside of their control, be it war, famine, or countless other issues, they have never been able to have this sustainable employment. We aim to bridge that gap, helping those people obtain the job skills that they need to succeed. Cigarette Lighter Airport Jammer Battlefield Cellphone Usage Global Navigation Satellite Systems, Inertial Navigation, and Integration by Mohinder S. Grewal, Angus P. Andrews, and Chris G. Bartone Link to full show notes and resources Guest Bio: Doug Abdiel is Global VP Customer Experience and Support at Advanced Navigation, a global leader in autonomous systems and navigation technology. In addition to being a Navigator, Doug is a U.S. Marine, and has served on active duty and in the reserves, where he is currently a Lieutenant Colonel, since 2003. Doug is an experienced leader with a record of driving change in the internet, defence, and social sectors for the past two decades. He has practiced in competitive intelligence, strategic/operational planning, and partnership business development across the Asia-Pacific. Doug is recognized for high-double-digit YoY growth and concurrent cost reduction on eleven-figure P&Ls. He is a community-minded founder, director, and chair of a multimillion-dollar social enterprise that provided over 50 people their first, and most importantly a pathway to their second, jobs in Australia. Doug's opinions are his own and do not necessarily reflect the views of the US Department of War, Department of the Navy, or the US Marine Corps. About: The Information Professionals Association (IPA) is a non-profit organization dedicated to exploring the role of information activities, such as influence and cognitive security, within the national security sector and helping to bridge the divide between operations and research. Its goal is to increase interdisciplinary collaboration between scholars and practitioners and policymakers with an interest in this domain. For more information, please contact us at communications@information-professionals.org. Or, connect directly with The Cognitive Crucible podcast host, John Bicknell, on LinkedIn. Disclosure: As an Amazon Associate, 1) IPA earns from qualifying purchases, 2) IPA gets commissions for purchases made through links in this post.

121. Microdosing for Midlife: Stability & Nervous System Change (Week 4)Week 4 of Microdosing for Midlife explores how nervous system stability shapes identity, growth, and long-term change in midlife.Episode SummaryThis episode is part Week 4 of Microdosing for Midlife—a 12-part audio companion to the original Substack series.In this conversation, April expands on what it actually means to feel stable while undergoing change. Midlife often brings visible transitions—shifts in hormones, identity, relationships, ambition—but underneath those external markers is something quieter: the nervous system recalibrating itself. Rather than focusing on dramatic breakthroughs, this episode examines how safety, steadiness, and subtle internal shifts create sustainable growth.Instead of chasing intensity, April reflects on how microdosing can support capacity—capacity to tolerate discomfort, to remain present in uncertainty, and to integrate insight gradually. The real work is not in peak moments. It's in the ability to return to baseline without abandoning yourself.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USOne on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingPSYCHEDELIC COMPOUNDSThat No One Has Made But I Think I Would LoveEpisode Six: THALASSINE-7(7-OH-Mitragynine-DMT Conjugate / Sigma-2 Agonist / Cortistatin Analog)“The compound that puts you in the water. The water that is already in you.”✦Episode SummaryThis episode delivers a haunting, second-person narrative of THALASSINE-7, a purely theoretical psychedelic that doesn't flood you with new visions — it turns up the volume on what your body is already screaming, clears the static of self-protection, and holds you in crystal-clear confrontation with the self at depth.Framed through a father and his nine-year-old daughter's real-time fight against a rip current at Three Tables Beach on Oahu's North Shore, the “trip” becomes an unflinching mirror for overconfidence, the weight of trust, ignoring warning signs, and the difference between survival and wisdom.The Compound (Theoretical Pharmacology)•  Backbone: Modified 7-hydroxymitragynine redirected from opioid receptors to sigma-2 agonism (mitochondrial receptors that govern the cellular “continue or quit” decision — literally apoptosis/survival signaling).•  Psychedelic Link: 5-substituted DMT moiety connected via sulfonyl linker, creating allosteric cross-talk that amplifies whatever signal your nervous system is already broadcasting instead of overlaying new hallucinations.•  Rest Component: Cortistatin-14 analog — the same neuropeptide your brain releases in deep slow-wave sleep — brought into full waking consciousness to quiet hippocampal chatter and deliver profound, low-static rest while you remain completely alert.Net Effect: Complete wakefulness + total removal of narrative armor + inescapable bodily truth = an encounter with reality you cannot file away.Status: 100% theoretical / fever-dream medicinal chemistry. No one has synthesized this. The lessons it forces are very real.The Trip Report: Three Tables Beach, Pupukea, North Shore OahuSetting: Overcast grey morning at the beach named for three flat coral reef tables visible at low tide. Multiple posted signs warn of powerful rip currents, hazardous shorebreak, and past deaths. The father enters the water anyway with his trusting daughter on his back.Key Moments (clinical timestamps from the narrative):•  T+0:00 — Reading the signs… and walking in.•  T+0:22 — The current slams. Sigma-2 receptors light up with the body's primal “continue” verdict.•  T+0:25–0:41 — Arm-over-arm fight; daughter silent, gripping, sixty-two pounds feeling like the entire world.•  T+0:58 — Shore reached. Arms shaking in six inches of water. Pride and reckoning land simultaneously.•  T+1:20 — The compound forces both truths at once: I brought her back and I never should have taken her in.•  T+2:00 — Integration on the sand: You are not the exception. Do the work in calm water before the current changes again.Real Location NoteThree Tables Beach (also called Kalua o Māua) is a real spot between Waimea Bay and Sharks Cove. It offers world-class snorkeling in summer but is notorious for sudden, powerful rip currents and rogue waves, especially October–April. Signs explicitly warn “Deaths have occurred,” “Strong rip currents capable of pulling swimmers far out to sea,” and “Enter at your own risk.” Recent incidents include drownings and rescues. There is no permanent lifeguard tower. Always check conditions and heed every sign.Core Themes & Takeaways•  The universal “gap at the sign” — the split-second where information becomes discomfort and we quietly decide “that doesn't apply to me.”•  Holding both pride in what your body refused to quit and accountability for the unnecessary risk.•  The ocean as the cleanest laboratory: it applies the same physics to everyone regardless of how much you love the person beside you or how strong your story says you are.•  Capacities are not equal — this is physics, not morality. The ethical response is ruthless honesty about where you actually are and deliberate work to close the gap.•  Parenting in action: what you model when the signs are clear echoes louder than any lecture.•  “Go do the work. In calm water. Before the current changes again.”Key Quote“You are not the exception. You are a person who, when the situation became the thing it was always warning you it might become, found out what you are actually made of. And what you are made of was enough. This time.”Synthesist's NotesThe specific conjugate (sulfonyl-linked 7-OH-mitragynine-DMT-cortistatin analog) exists only in speculation, but every piece draws from documented science: sigma-2 receptors in mitochondria, cortistatin's role in deep sleep consolidation, and the well-known potency of 7-hydroxymitragynine. What is not speculative is the psychological target — the moment we read a warning and override it with self-flattery. THALASSINE-7 is the compound that refuses to let you file that discomfort under “confidence” and keeps the gap open until it becomes transformation.Next EpisodeCHRONOGEN — a peptide-psychedelic hybrid that does not alter time perception. It alters time preference. The body begins to want the present with such ferocity that past and future lose their gravitational pull. The calendar has been keeping records of every appointment your future self never received. It is not angry. It is just waiting.✦END OF EPISODE SIXTHALASSINE-7 • Status: Theoretical. The signs were always right.Thank you for listening (or reading). If this episode moved you, sit with the gap at your own signs today. The water is already in you. One on One Video call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_US

The EU and its member states are weighing the costs and benefits of offering Ukraine a fast-track accession process, while also considering how to manage relations with other candidate countries. Rosa Balfour, Sylvie Goulard, and Gerald Knaus examine how further enlargement could shape the EU's cohesion, decisionmaking capacity, and ability to act effectively on the global stage. [00:00:00] Intro, [00:01:02] Could a Smaller EU Be Stronger than an Enlarged Bloc?, [00:32:37] The Future of EU Enlargement. Rosa Balfour, March 25, 2025, “The Case for Europe,” Strategic Europe, Carnegie Europe. Rosa Balfour, October 3, 2024, “EU Should Enlarge, Even Out of Despair,” Visegrad Insight. Dimitar Bechev, Iliriana Gjoni, October 28, 2025, “How the Western Balkans Can Contribute to European Defense,” Strategic Europe, Carnegie Europe. Stefan Lehne, Zoran Nechev, Richard Grieveson, August 27, 2025, “Access Before Accession: Rethinking the EU's Gradual Integration,” Carnegie Europe. Rym Momtaz, February 10, 2026, “To Survive, the EU Must Split,” Strategic Europe, Carnegie Europe.

Josh Rogin explains how the CCP exploits academic integration through the Thousand Talents Plan and how Wall Street continues to resist decoupling despite national security risks. 6

Lorraine Marchand, startup CEO, advisor to Johnson & Johnson, member of the Pharmaceutical Advisory Board at Columbia Business School, and faculty at Wharton, discusses how leaders can sustain growth through disciplined experimentation in an era shaped by AI and institutional risk aversion.  Marchand's perspective is grounded in a career that spans large corporations and entrepreneurial ventures. Early in life, she learned to treat problem solving as an experiment rather than a test of personal worth. That principle later informed her approach to innovation in complex organizations. Several practical themes emerge from the discussion: 1. Reframe failure as structured learning. Marchand's operating principle is "try, fail, learn." The key is to set explicit learning objectives before undertaking a new initiative. When leaders define what they intend to learn, not just what they intend to achieve, they reduce fear and increase resilience. This mindset is particularly critical in startups and new ventures, where there is no playbook and early missteps are inevitable. 2. Innovation requires protected investment. Drawing on research and executive interviews, Marchand highlights the value of disciplined portfolio allocation. A 70/20/10 model—70% core business, 20% adjacent opportunities, 10% new, exploratory ideas—creates room for experimentation without destabilizing the enterprise. The evidence she cites suggests that long-term growth frequently emerges from ideas that initially seemed peripheral. 3. Culture often suppresses experimentation. Organizations frequently default to "playing it safe." Marchand argues that leaders must explicitly create space for candor and reflection. Her practice of "Fail Free Friday", a structured forum to discuss what is not working without defensiveness, illustrates how small rituals can normalize learning and surface risk before it compounds. 4. AI should assist thinking, not replace it. Marchand observes both curiosity and fatigue around AI. Students and executives alike risk over-reliance, which can erode depth of analysis. Her discipline is simple: think independently first, then use AI as a research assistant to refine or challenge one's reasoning. Senior leaders remain relevant not by competing with automation, but by asking the right questions, an ability rooted in experience and judgment. 5. Integration of technology requires business judgment. Technology cannot be bolted onto processes indiscriminately. Leaders must understand workflows deeply enough to decide where automation adds value, where human ingenuity remains essential, and where both are required. This integration demands clarity about the business, not just familiarity with the tool. 6. The "who" and the "how" matter more than the "what." Late-career reflection led Marchand to conclude that outcomes achieved at the expense of people erode long-term value. Values alignment, integrity, and disciplined focus, often expressed through the willingness to say no, are strategic decisions, not personal preferences. For senior professionals, the message is direct: sustained growth depends less on bold rhetoric and more on creating disciplined environments where experimentation is safe, technology is used thoughtfully, and people are encouraged to think independently. The capacity to ask better questions, protect time for reflection, and allocate resources to uncertain but promising ideas remains a defining leadership advantage. Lorraine H. Marchand, an acclaimed author and innovator, is author of the new book NO FEAR, NO FAILURE and a leading consultant and educator on innovation with deep expertise in new product development. She has cofounded multiple start-ups, held senior roles at global companies including Bristol-Myers Squibb, Covance/LabCorp, and IBM, and advises top organizations while teaching at the Wharton School and Yeshiva University. Get Lorraine's book, No Fear, No Failure, here: https://tinyurl.com/eksdu9ks Claim your free gift: Free gift #1 McKinsey & BCG winning resume www.FIRMSconsulting.com/resumePDF Free gift #2 Breakthrough Decisions Guide with 25 AI Prompts www.FIRMSconsulting.com/decisions Free gift #3 Five Reasons Why People Ignore Somebody www.FIRMSconsulting.com/owntheroom Free gift #4 Access episode 1 from Build a Consulting Firm, Level 1 www.FIRMSconsulting.com/build Free gift #5 The Overall Approach used in well-managed strategy studies www.FIRMSconsulting.com/OverallApproach Free gift #6 Get a copy of Nine Leaders in Action, a book we co-authored with some of our clients: www.FIRMSconsulting.com/gift

Dr. Amel Havkic, founder of EvoMed Consulting and a lung and critical care specialist, hospital clinical lead. Amel works at the intersection of bedside medicine and MedTech strategy, helping innovators build clinician-approved solutions that scale safely across real healthcare systems.In this episode, we unpack why “clinicians love it” is rarely enough to win adoption, and what hospital purchasing actually looks like when procurement, IT, finance, compliance and workflows all have a seat at the table. Amel breaks down why switching away from legacy tools is painful, how integrations can break care pathways, and why solutions that feel like a natural part of the hospital ecosystem win faster. He also shares a practical lens for building frictionless implementation by aligning with standards like HL7, FHIR and DICOM, while proving measurable value for patients and payers.We also go deep on decentralising healthcare. Amel explains how the Dutch model centralises high-end expertise while decentralising access through remote monitoring and home-based onboarding, and why this becomes a winning approach as staffing pressures rise. On AI, he makes the case for reframing it as augmented intelligence, not autonomy, and shows where decision support can raise the baseline of care by supporting clinicians in time-critical situations, as well as offloading admin burden that drains capacity.Finally, Amel shares the thinking behind the EMC StarMap framework, a navigation tool built from real-world patterns of what makes MedTech succeed or fail. His core message is simple: regulatory approval is a milestone, but clinical adoption is the real finish line.Timestamps[00:00:05] Clinician + Consultant Lens: Seeing Adoption and Safety Risks[00:01:22] Why “Physicians Love It” Does Not Mean Hospitals Will Buy[00:03:27] What Hospitals Consider Beyond Cost: Workflow, Integration and Training[00:05:09] Frictionless Implementation: Standards, EHR Fit and “Team Player” Products[00:06:24] Real Clinical Workflow: ICU Reality and Why UI Clicks Matter[00:07:31] Decentralising Care: Centralised Expertise With Home-Based Delivery[00:10:37] AI in Healthcare: Reframing as Augmented Intelligence[00:12:55] Staffing Shortages: Where AI Can Remove Waste and Scale Expertise[00:14:38] If You Could Change One Thing: Put the Patient Back at the Center[00:16:59] StarMap: Measuring What Drives Clinical AdoptionConnect with Rick - ⁠⁠⁠⁠https://www.linkedin.com/in/a-havkic/Learn more about Evomed Consulting - https://evomed-consulting.eu/Get in touch with Karandeep Badwal - ⁠⁠⁠⁠⁠https://www.linkedin.com/in/karandeepbadwal/ ⁠⁠⁠⁠⁠Follow Karandeep on YouTube - ⁠⁠⁠⁠⁠https://www.youtube.com/@KarandeepBadwal⁠⁠⁠⁠⁠Subscribe to the Podcast

In this episode of Clemenz With a “Z,” I reflect on what happens on the other side of healing. We talk a lot about wounds and unraveling, about leaving and deconstructing, about anger and survival. But what about integration? What about the quiet phase where you're no longer bleeding yet you're not who you used to be either? Through the metaphor of physical scars and the unseen marks we carry in our minds and nervous systems, this episode explores the idea that healing doesn't erase the mark, it transforms it. If you've ever wondered why certain words still make your chest tighten, or why tenderness lingers even after growth, this conversation is for you. Scars don't shout. They hum. And that hum might just be wisdom. If anything in this episode resonated with you and you would like to reach out to me you can drop me a line at clemenzwithaz@gmail.com or drop a DM at the clemenz with a "Z" instagram page.   You can head over to https://gofund.me/7ebb0524 every bit helps. And if you're looking for more reflection, honesty, and spiritual wrestling, check out my Substack: Devotions for the Deconstructing & Disillusioned, it's a space for people who still have soul, but no longer fit in the boxes they were handed. Thanks for being here.

In this episode, host Sandy Vance and Ted Dinsmore discuss the ever-evolving role of AI in healthcare, industry trends, challenges, and solutions. They explore the concept of agentic AI and the Model Context Protocol (MCP), which aims to enhance data integration and efficiency in healthcare systems. They also highlight the importance of building trust in AI solutions, particularly in rural healthcare settings. Listen in to learn how SphereGen is addressing these challenges through innovative AI implementation approaches. In this episode, they talk about: Latest AI trend: agentic AI and bots, and MCP in the healthcare industry MCP allows us to speed up that integration Trust is a huge issue when you're having an impact on the patient The benefits of using MCP for hospitals and patients The concerns about the changes and cuts to rural healthcare The most common use cases when transitioning: eligibility, prior authorization, and denials management The effects on how healthcare systems are doing business with EHRs Next big use cases and what's coming up next Solving challenges in rural healthcare over the next few years How rural healthcare and homecare are tied At the end of the day, it's all about how AI can help free up time for people A Little About Ted: Ted Dinsmore is the President of SphereGen Technologies, located in New Haven, Connecticut, Toronto, Canada, and Pune, India. SphereGen is a software consulting firm that develops and supports custom software solutions for clients in AI and Automation, Application Development, and Extended Reality (AR, VR, MR). His experience in the world of IT spans over 30 years. When Ted started his first consulting firm, he became invested in developing and supporting Microsoft solutions for large multinational companies. Wanting to stay at the forefront of emerging technologies, his current company, SphereGen, embraces the world of AI/Automation and Mixed Reality (MR). SphereGen focuses on improving processes for healthcare organizations by leveraging innovative technologies, along with partners UiPath and Microsoft, to solve business problems.

Maslows Bedürfnispyramide kennt fast jede:r – aber was, wenn sie so nie gedacht war? Woher kommt sie eigentlich, warum ist sie bis heute so mächtig und was daran ist wissenschaftlich haltbar? In dieser Folge nehmen Leon und Atze eine der berühmtesten Ideen der Psychologie auseinander. Dabei sprechen sie über Leitern statt Pyramiden, Segelboote mit Leck, falsche Vereinfachungen und die Frage, ob Menschen wirklich erst „oben ankommen“ müssen, um zu wachsen. Eine Folge über Mythen, gute Ideen, schlechte Grafiken – und darüber, was wir wirklich brauchen, um ein erfülltes Leben zu führen. Fühlt euch gut betreut Leon & Atze Instagram: https://www.instagram.com/leonwindscheid/ https://www.instagram.com/atzeschroeder_offiziell/ Mehr zu unseren Werbepartnern findet ihr hier: https://linktr.ee/betreutesfuehlen Tickets: Atze: https://www.atzeschroeder.de/#termine Leon: https://leonwindscheid.de/tour/ Vorverkauf 2026: https://betreutes-fuehlen.ticket.io/ Quellen Bridgman, T., Cummings, S., & Ballard, J. (2019). Who built Maslow's pyramid? A history of the creation of management studies' most famous symbol and its implications for management education. Academy of Management Learning & Education, 18(1), 81–98. https://doi.org/10.5465/amle.2017.0351 Compton, W. C. (2024). Self-actualization myths: What did Maslow really say? Journal of Humanistic Psychology, 64(5), 743–760. https://doi.org/10.1177/0022167818761929 Cooke, B., & Mills, A. J. (2008). The fabrication of Maslow's hierarchy of needs. Academy of Management Proceedings, 2008(1), 1–6. https://doi.org/10.5465/AMBPP.2008.33633768 Davis, K. (1957). Human relations in business. McGraw-Hill. Hoffman, E. (1988). The right to be human: A biography of Abraham Maslow. Addison-Wesley. Kaufman, S. B. (2020). Transcend: The new science of self-actualization. TarcherPerigee. Kaufman, S. B. (2023). Self-actualizing people in the 21st century: Integration with contemporary theory and research on personality and well-being. Journal of Humanistic Psychology, 63(1), 51–83. https://doi.org/10.1177/0022167818809187 Maslow, A. H. (1943). A theory of human motivation. Psychological Review, 50(4), 370–396. https://doi.org/10.1037/h0054346 Maslow, A. H. (1970). Motivation and personality (2nd ed.; Original work published 1954). Harper & Row. McDermid, C. (1960). How money motivates men. Business Horizons, 3(4), 93–100. https://doi.org/10.1016/0007-6813(60)90004-3 McGregor, D. (1960). The human side of enterprise. McGraw-Hill. Oishi, S., Diener, E., Lucas, R. E., & Suh, E. M. (1999). Cross-cultural variations in predictors of life satisfaction: Perspectives from needs and values. Personality and Social Psychology Bulletin, 25(8), 980–990. https://doi.org/10.1177/01461672992511006 Sheldon, K. M., Elliot, A. J., Kim, Y., & Kasser, T. (2001). What is satisfying about satisfying events? Testing 10 candidate psychological needs. Journal of Personality and Social Psychology, 80(2), 325–339. https://doi.org/10.1037/0022-3514.80.2.325 Tay, L., & Diener, E. (2011). Needs and subjective well-being around the world. Journal of Personality and Social Psychology, 101(2), 354–365. https://doi.org/10.1037/a0023779 Wahba, M. A., & Bridwell, L. G. (1976). Maslow reconsidered: A review of research on the need hierarchy theory. Organizational Behavior and Human Performance, 15(2), 212–240. https://doi.org/10.1016/0030-5073(76)90038-6 Redaktion: Dr. Leon Windscheid Produktion: Murmel Produktions

We've spent this month diving deep into energy management: why time management alone isn't enough, the practical toolkit you need, and how to use energy as your career navigation system.Today, we're bringing it all together.This is a two-part integration episode designed to help you move from information to action.Part 1 is a coaching session. Just you and me, working through the questions that turn awareness into commitment. I'll guide you through three reflection questions, help you identify your ONE thing, and walk you through making a concrete commitment you can actually keep.Part 2 is a Q&A where I answer the three most common questions I received this month:→ "I'm in the wrong role but I can't just quit. What do I do?"→ "How do I protect my Genius Zone time when my manager keeps scheduling over it?"→ "I've tried to change before and it never sticks. Why would this time be different?"Submit your questions here: https://forms.gle/VmcXEA6E52qdHyKN8

Mini Retreat: Meditate with Me Integration class — Stability in Motion: Restoring Action to the Body — in the Live class a profound structural shift opened in the field, including a Reiki upgrade that moved through during the session. And since then many in the Inspiring You Patreon have messaged to tell them they also felt and experienced it. I felt called to share this publicly for everyone. Because of the intensity unfolding collectively right now, and because this class speaks directly to the moment we are living in, I wanted to offer this practice publicly so a wider circle can receive the support.This class is part of our February 2026 series, Living the Light Format in Function — a series devoted to coherence, where movement does not disrupt your structure and expression does not scatter your field. Each class stands fully on its own, and this episode can be used as a single-session practice or expanded into a mini-retreat by engaging all five meditation parts together.The teaching in this class carries universal resonance. This meditation opens a field of coherence so you can stay connected to yourself while life moves around you.During the meditation, you may here the word "Format" or "Light Format" Why the Guides use the word “Format”: Format is the harmonic architecture of Soul coherence made lived and structural. It is not a technique, but the stabilized field through which your Light expresses without distortion. Light in physical form. Format is the inner architecture that allows you to move, speak, and relate without leaving yourself.What this class supports:Staying rooted in your Light Format while in motion; integrating after visibility without collapse; breathing from structural rhythm rather than modulation; releasing the reflex to track, adjust, or perform; remaining coherent without withdrawing or bracing.This session reminds you that stability is not stillness — it is the resonance of your structure. You are safe because you remain with yourself.Five-Part Practice (included in the episode):• Part 1: Crystalline Format Field Entrainment — anchoring motion inside the Light Format.• Part 2: Output Integration — dissolving depletion linked to visibility.• Part 3: Nervous System Resonance — releasing post-action alertness.• Part 4: Tri-Wave Breath of Format — sealing motion from within rather than matching the external field.• Part 5: Soul Listening in Action — staying internally referenced while relating.You may listen to the entire practice sequentially as a mini-retreat, or choose one part that meets your field today. Either way, the session supports motion without distortion, expression without exit, and coherence that does not depend on recovery.—

​Larry Jones is the Executive Director of the IP Network, and CEO of HPOF Holdings, LLC, doing business as Independent Healthcare Partners, a healthcare company headquartered in Maitland, Florida. As the CEO of HPOF Holdings/IHP, his main mission is to preserve and protect the independent practice of medicine. Larry has been on both the payer and provider side of healthcare. He served on the Business Advisory Board of Seminole County Public Schools for 12 years, representing the insurance committee and 9000 employees' lives and almost $60M in premium. He is a founding board member of the Florida Association of ACOs. His organization currently runs our large Multi Specialty IPA - the IP Network - and Physicians Trust MSO, overseeing two Commercial ACO contracts and four Medicare Advantage Plan agreements for our Network.Larry has spoken all over the Country on physician issues and opportunities.​He is a true physician advocate. Mark Steven Chaet, M.D. serves as the Orlando Regional Campus Dean. In this role, he oversees all campus functions including supervising clerkship directors, student education and performance, and student counseling. The regional campus dean's role at the FSU College of Medicine is unique as he plays an expanded role with students, including direct contact, comprehensive mentoring, and one-on-one interaction when needed. Additionally, fundraising is an increasingly important role of the campus dean in efforts to fund local operations and scholarships for students. Dr. Chaet, a pediatric surgeon on staff at both Orlando Health Arnold Palmer Hospital for Children and Advent Health Children’s Hospital, has been practicing in the Orlando area since 1997. Serving as an FSU Orlando community faculty member since 2003, Dr. Chaet has shown a commitment to education throughout his career. He has served on the teaching faculty for general surgery residents at both Orlando Health and Advent Health, been a preceptor for physician assistant and nurse practitioner candidates from Nova Southeastern University, the University of South Florida, and the University of South Alabama, and continues to serve as faculty for the Surgical Intern Program at the University of Central Florida. Dr. Chaet has shown great community involvement over the years, both on a local and national level, serving on various committees in the Orlando area and working as consultant for opioid reduction. As a Lt. Colonel in the United States Army and Reserve from 1991-2007, Dr. Chaet trained as a field trauma surgeon and supported medical deployments during both Operation Desert Storm and Operation Enduring Freedom. Dr. Chaet has been involved in a number of research efforts over the years focusing on pediatric surgery and gastroenterology and continues to display a commitment to leadership and ongoing professional development. See omnystudio.com/listener for privacy information.

In dieser Episode diskutieren Hannah und Marco verschiedene aktuelle Themen, darunter die Auswirkungen neuer Trinkgeldregelungen in New York, die Einwanderungspolitik von Donald Trump und die Dringlichkeit wirtschaftlicher Zusammenarbeit in der EU. Sie beleuchten die Herausforderungen, die sich aus Trumps Politik ergeben, insbesondere in der Bauwirtschaft, und erörtern die Notwendigkeit einer Kapitalmarktunion zur Stärkung der europäischen Wirtschaft. In dieser Episode diskutieren Hannah und Marco über die Herausforderungen und Chancen der europäischen Wirtschaft, insbesondere in Bezug auf Bürokratieabbau, Fusionen, Energieintegration, strategische Industriepolitik und den Klimawandel. Sie beleuchten die Notwendigkeit, europäische Champions zu fördern und die Wettbewerbsfähigkeit im globalen Markt zu stärken, während sie auch die politischen Hürden und nationalen Interessen ansprechen, die eine tiefere Integration behindern. Zudem wird das Handelsabkommen mit Indien und die geopolitischen Dynamiken, die damit verbunden sind, thematisiert. (Zusammenfassung von Riverside AI)

For over a decade, Jordan Sather has stood at the front lines of the digital information war — building one of the earliest independent platforms decoding Q in real time, getting banned from nearly every major platform during the censorship purge, and continuing to investigate the deeper layers of power, influence, and corruption behind stories like Epstein, intelligence blackmail networks, Pizzagate and the battle between mainstream and alternative media. In this wide-ranging and grounded conversation, Jordan walks us through his personal awakening, the rise (and infiltration) of the Q movement, the truth and distortion surrounding the Epstein files, and the psychological traps that can derail even the most sincere truth-seekers. You will not find blind allegiance or doom-fueled paranoia here — it's a sober exploration of psyops, influence operations, and the responsibility that comes with knowing. If you care about discernment in a chaotic age, this episode is essential listening.Time Stamps (00:00) Episode Teaser (00:34) Opening Conversation (04:37) Understanding Ibogaine and Its Effects (06:25) The Healing Power of Ibogaine (25:24) The Definition of Self-Love That Was Revealed (33:35) Intergenerational Healing (40:51) Reverence vs. Worship: Understanding the Difference (42:43) Yerasimos' Ayahuasca Experience (46:27) The Role of the Medicine in Personal Development (52:54) The Supplemental Dose: Processing Emotions and Ancestral Trauma (01:00:30) Integration and the Challenges of Returning to Normal Life (01:03:09) The Relationship Between Self-Betrayal and Self-Love (01:15:20) The Importance of Intent and Reverence in Medicine Work (01:22:28) Surrender and Trust: Lessons from the Divine Realm (01:27:25) Setting Intentions and Personal Reflections (01:30:09) The Impact of Social Media and Technology (01:40:37) Voluntarism and Political Philosophy (01:43:49) Personal Growth and SpiritualityGuest Linkshttps://www.jordansather.com/ Connect with UsJoin our membership Friends of the TruthRise Above The Herd Take the Real AF Test NowDiscover Your Truth Seeker ArchetypeWatch all our episodesConnect with us on TelegramFollow us on InstagramAccess all our links

In this episode of the CPQ Podcast, we sit down with Dustin Anglen, Strategic Partnerships Manager at PandaDoc, to discuss how PandaDoc CPQ supports faster quoting for SMB teams (roughly 5–500 employees). PandaDoc is widely known for proposals and eSignature, and Dustin explains why CPQ is a natural extension—especially for organizations that want a practical, easy-to-administer approach without heavy configuration overhead. We cover where PandaDoc CPQ fits best (including SaaS, software & technology, professional services, and education) and how customers typically use it alongside their CRM. Dustin outlines PandaDoc's API-forward SaaSapproach and its key integrations with HubSpot, Pipedrive, and Salesforce. We also discuss what's available today—and what's still evolving—such as ERP connectivity (currently not a standard integration, with MVP work underway) and common customer expectations around implementation, which is often 8–12 weeks. On the capability side, Dustin shares the top requests he sees from the market: product configuration, contract-based pricing, and CRM integration. We talk about product structure support (including bundles), pricing flexibility across segments and regions, usage-based pricing, and how PandaDoc positions its CPQ as a rules engine that is largely no-code (with options for more advanced logic when needed). We also dig into PandaDoc's AI direction—template generation, OCR and document intelligence, metadata-driven automation, and an admin-focused AI feature for helping set up product and pricing rules (currently in testing, with broader availability expected later this year). You'll also hear a few personal moments from Dustin—from his early career in the Salesforce ecosystem (including starting at Apttus in 2014), to an unexpected chapter running a beekeeping business in Santa Barbara, to his passion for freediving near San Diego. A PandaDoc CPQ free trial is available on PandaDoc's website.

In this episode of The Distribution, Brandon Sedloff sits down with Steven DeFrancis, Founder and CEO of Cortland, to unpack how multifamily evolved from a commodity product into a true consumer service business. Steven shares the story behind Cortland's transformation from a small merchant builder into a vertically integrated investment manager with more than 75,000 units and $20 billion in gross asset value. The conversation explores why operational depth, brand trust, and technology infrastructure now sit at the center of performance in living real estate. Steven walks through the post-GFC research that reshaped Cortland's strategy, the demographic shifts that extended renter lifecycles, and the deliberate decision to build operational infrastructure long before raising institutional LP capital. He also details how brand equity translates directly into pricing power, retention, and investor returns, and why scale is increasingly essential in a consolidating market. They discuss: The pivot from merchant development to a vertically integrated operating platform Why multifamily shifted from a commodity to a consumer service business How brand trust creates measurable top-line rent premiums and longer resident tenure The role of data, AI, and centralized workflows in reducing fraud, speeding leasing, and improving performance Why 2026 and beyond may present compelling acquisition opportunities amid capital market stress and supply overhang Links: Cortland - https://cortland.com/ Steven on LinkedIn - https://www.linkedin.com/in/steven-defrancis-022a564/ Brandon on LinkedIn - ⁠https://www.linkedin.com/in/bsedloff/⁠ Juniper Square - ⁠https://www.junipersquare.com/⁠ Topics: (00:00:00) - Intro (00:03:21) - Steven's background and career (00:13:48) - Building Cortland and lessons from the GFC (00:20:06) - Building a vertically integrated operating platform (00:24:13) - Raising institutional LP funds (00:28:02) - Cortland's scale, markets, and fund vehicles (00:34:22) - Operational alpha (00:42:20) - 2026 market outlook (00:50:40) - Tech and AI in multifamily (00:55:28) - Advice for operators (01:00:11) - Closing thoughts

In this conversation, Stephan Livera and Keith from Branta discuss the intricacies of Bitcoin payments, focusing on the importance of address verification and security in the context of increasing digital threats. They explore how Branta's zero-knowledge verification process can enhance user experience and security, particularly in the face of potential scams and malware. The discussion also touches on the integration of Branta with Lightning and other Layer 2 solutions, as well as the future of Bitcoin user experience in an AI-driven world.Takeaways:

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Episode Highlights With PaulHis journey to get to the work he does now The metaphor of dance and how it relates to everythingSomatic healing and how it comes into play“It's sacred, not serious.”What the Habit Finder is and how this gives different information than regular personality testsInductive assessments vs deductive assessment like the Habit Finder Identity is very fluid and trauma can often become a core element of identity Trauma is not what happened to you, its what's going on inside of youThe body was never meant to be a storage facility for the energy of trauma which is trapped energy Every human has experienced the most traumatic thing a human can experience in birthFinding authenticity in the function of the game we are all playing We thought the brain was the command center, but it actually receives more guidance from the body than it sendsThe energy it takes to build something will always be the energy it takes to maintain itYour life is exactly as you need it to be and how understanding this can shift so muchThe liminal space that lets life be easier and more successful, can be accessed, and how to learn howThe difference between obligation and devotionWhat a horizontal relationship is and why this is so important Why many of the things we do that we think are for our children are actually for our own benefitIf your child lies to you, its because they don't feel safe. That doesn't mean its ok, just that it requires different intentionAfter age 7, the primary role of a parent is to be the safe place for them to come back to when they experience the worldWhy to reconsider not giving advice that isn't asked for even with our children!The devil is only the devil when it is rejectedResources MentionedFollow Paul on Facebook and InstagramHabit Finder Assessment: Measure Your Unconscious Brain PatternsUnmarketability Test

Industrial Talk is talking to Klaus Andersen and Nils Olsson with Tacton about "Redefining buyers engagement for manufactures of complex products". Scott Mackenzie introduces Elevo Tech, a company offering ERP, EAM, and business intelligence solutions, and then transitions to discussing Tacton, a Swedish company specializing in advanced manufacturing configuration. Tacton's CPQ solutions help customers configure complex equipment, supporting both direct sales and omnichannel interactions. The platform integrates with existing systems like CRM, PLM, and ERP, aiming to increase win rates, efficiency, and reduce errors. Tacton's AI capabilities can cut configuration time by up to 80% by structuring unstructured product data. Implementation times vary, typically between six months and a year, depending on the project's scope. Outline Introduction to Elevotec and Industrial Talk Podcast Scott Mackenzie introduces Elevotec, highlighting their ERP, EAM, and business intelligence solutions.Scott Mackenzie welcomes listeners to the Industrial Talk Podcast, emphasizing the importance of celebrating industry professionals.Scott Mackenzie introduces Klaus and Nils from Tacton, discussing their platform and its solutions for today's challenges.Scott Mackenzie expresses excitement about the renaissance in industrial solutions and the importance of human-to-human connection in marketing. Challenges and Solutions in Advanced Manufacturing Nils explains Tacton's specialization in configuring complex equipment, comparing it to configuring consumer products like computers or cars.Klaus describes Tacton's CPQ solutions for advanced manufacturing, supporting both direct sales and omnichannel support.Scott Mackenzie and Klaus discuss the importance of making the configuration process easy for customers while ensuring technical accuracy.Nils emphasizes the need for a buyer-centric smart factory, making it easy for customers to navigate the solution space without technical expertise. Integration and Flexibility of Tacton's Solutions Scott Mackenzie inquires about Tacton's integration with existing IT systems like CRM, PLM, and ERP.Nils explains that Tacton is an agnostic player, able to augment existing systems without complete reconfiguration.Scott Mackenzie and Nils discuss the financial benefits of Tacton's solutions, including increased win rates, efficiency, and reduced errors.Klaus highlights the importance of accurate quotes and the impact of errors on warranty costs and rework. Customer-Centric Pricing and Data Management Scott Mackenzie asks about the flexibility of Tacton's pricing methods, including value-based pricing and detailed bill of materials.Nils explains that Tacton supports various pricing methods, depending on the business needs.Scott Mackenzie inquires about how Tacton ensures the system stays updated with the latest product changes and data.Nils describes the typical setup of connecting PLM and CPQ systems to ensure data accuracy and timeliness. Implementation Time and AI Integration Scott Mackenzie asks about the implementation time for Tacton's solutions.Klaus estimates the implementation time to be between six months and a year, depending on the project's scope.Scott Mackenzie inquires about Tacton's use of AI in their solutions.Nils explains that AI is used to structure unstructured product data, significantly reducing the time required for configuration. Future Challenges and Market Reception Scott Mackenzie asks about the future challenges and opportunities for Tacton.Klaus and Nils discuss the...